INTERNATIONAL PATENT: ASTELLAS GENE THERAPIES, INC. FILES APPLICATION FOR "MUSCLE SELECTIVE HYBRID REGULATORY COMBINATIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1"

GENEVA, July 30 -- ASTELLAS GENE THERAPIES, INC. (480 Forbes BoulevardSouth San Francisco, California 94080) filed a patent application (PCT/US2025/011882) for "MUSCLE SELECTIVE HYBRID REGULATORY COMBINATIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1" on Jan 16, 2025. With publication no. WO/2025/155722, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NACHTRAB, Gregory Thomas (c/o ASTELLAS GENE THERAPIES, INC.480 Forbes BoulevardSouth San Francisco, California 94080), BATRA, Ranjan (c/o AST...